REMD is a trailblazing innovator of irreversible electroporation technology, with a focus on the research, development, production, and sale of advanced medical equipment for tumor treatment. Its core technology lies in high-frequency irreversible electroporation. The company recently secured a significant CNY100.00M Series A investment on 17 February 2023, with funding from Qianzhan Investment Management, Zhejiang Silicon Paradise Asset Management Group, and Datong Capital. REMD's dedication to advancing tumor treatment makes it a compelling prospect for venture capital investment in the medical technology industry.
remd
Advancing tumor treatment with high-frequency irreversible electroporation technology at its core.
Series A
Total: $100.00M
Medical Devices
General Information
Company Name
remd
Industries
Medical Devices
Funding Stage
Series A
Social
BounceWatch is an independent company data service, not affiliated with remd. To contact remd, visit remd.cn.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does remd compare?
A PDF of remd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting remd soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is remd on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About remd
Business keywords: tumor treatment, medical equipment, irreversible electroporation technology, high-frequency technology, innovation, advanced medical equipment, oncology technology, cancer treatment
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | CNY100.00M | 3 |
Qianzhan Investment Management, Zhejiang Silicon Paradise Asset Management Group +1
|
17 Feb 2023 |
remd Alternatives & Competitors
View All Alternatives
remd vs
Pioneering the future of high-end medical devices in peripheral vascular intervention, tumor interve...
Series A
Medical Devices
remd vs
Alpha Tau Medical
Israel
Revolutionary Alpha Emitters Radiotherapy
Post-IPO Equity
98 employees
Health Care, Medical Devices
remd vs
Novian Health
United States
A LEADING COMPANY IN IMAGE-GUIDED LASER TUMOR THERAPY
Convertible Note
9 employees
Health Care, Health and Wellness
FAQ About remd
Advancing tumor treatment with high-frequency irreversible electroporation technology at its core.
remd operates in Medical Devices. Its work centres on tumor treatment, medical equipment, irreversible electroporation technology and high-frequency technology.
remd has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series A.
Top alternatives and competitors to remd include Suzhou Meichuang, Alpha Tau Medical, Novian Health, OncXerna Therapeutics , ABK Biomedical Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
remd and Suzhou Meichuang are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for remd, https://bouncewatch.com/company/remd, updated 11 November 2024. When citing, please name BounceWatch and link this page.
